AGIOS PHARMACEUTICALS, INC. Operating Lease, Payments in USD from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2025.
  • Agios Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2025 was $4.92M, a 4.95% increase year-over-year.
  • Agios Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2025 was $19.4M, a 4.22% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Operating Lease, Payments for 2024 was $18.7M, a 2.94% increase from 2023.
  • Agios Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $18.2M, a 6.66% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $17M, a 18.2% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $19.4M $4.92M +$232K +4.95% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 $19.1M $4.91M +$233K +4.98% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $18.9M $4.84M +$184K +3.95% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $18.7M $4.69M +$134K +2.94% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 $18.6M $4.68M +$134K +2.95% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 $18.4M $4.68M +$134K +2.95% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $18.3M $4.65M +$133K +2.94% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 $18.2M $4.56M +$131K +2.96% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 $18M $4.55M +$130K +2.94% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $17.9M $4.54M +$130K +2.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $17.8M $4.52M +$744K +19.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $17M $4.43M +$828K +23% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 $16.2M $4.42M +$806K +22.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $15.4M $4.41M +$814K +22.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $14.6M $3.78M +$176K +4.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $14.4M $3.6M +$73K +2.07% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $14.3M $3.61M +$114K +3.26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $14.2M $3.6M +$100K +2.86% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $14.1M $3.6M -$300K -7.69% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $14.4M $3.52M -$776K -18% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $15.2M $3.5M +$1.3M +59.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $13.9M $3.5M +$300K +9.38% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $13.6M $3.9M +$800K +25.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $12.8M $4.3M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $2.2M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.2M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $3.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30

AGIOS PHARMACEUTICALS, INC. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $18.7M +$535K +2.94% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $18.2M +$1.14M +6.66% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $17M +$2.62M +18.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $14.4M -$13K -0.09% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $14.4M +$1.62M +12.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $12.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.